BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20451232)

  • 1. Enhanced human papillomavirus type 8 oncogene expression levels are crucial for skin tumorigenesis in transgenic mice.
    Hufbauer M; Lazić D; Akgül B; Brandsma JL; Pfister H; Weissenborn SJ
    Virology; 2010 Aug; 403(2):128-36. PubMed ID: 20451232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of skin tumors in mice transgenic for early genes of human papillomavirus type 8.
    Schaper ID; Marcuzzi GP; Weissenborn SJ; Kasper HU; Dries V; Smyth N; Fuchs P; Pfister H
    Cancer Res; 2005 Feb; 65(4):1394-400. PubMed ID: 15735026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous tumour development in human papillomavirus type 8 E6 transgenic mice and rapid induction by UV-light exposure and wounding.
    Marcuzzi GP; Hufbauer M; Kasper HU; Weißenborn SJ; Smola S; Pfister H
    J Gen Virol; 2009 Dec; 90(Pt 12):2855-2864. PubMed ID: 19692543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced StefinA and Sprr2 expression during papilloma formation in HPV8 transgenic mice.
    Lazić D; Alborzi F; Marcuzzi GP; Angel P; Hess J; Pfister H; Akgül B
    J Dermatol Sci; 2011 May; 62(2):84-90. PubMed ID: 21458245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E6/E7 expression of human papillomavirus type 20 (HPV-20) and HPV-27 influences proliferation and differentiation of the skin in UV-irradiated SKH-hr1 transgenic mice.
    Michel A; Kopp-Schneider A; Zentgraf H; Gruber AD; de Villiers EM
    J Virol; 2006 Nov; 80(22):11153-64. PubMed ID: 16971438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin tumor formation in human papillomavirus 8 transgenic mice is associated with a deregulation of oncogenic miRNAs and their tumor suppressive targets.
    Hufbauer M; Lazić D; Reinartz M; Akgül B; Pfister H; Weissenborn SJ
    J Dermatol Sci; 2011 Oct; 64(1):7-15. PubMed ID: 21763111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human papillomavirus type 8 E2 protein induces skin tumors in transgenic mice.
    Pfefferle R; Marcuzzi GP; Akgül B; Kasper HU; Schulze F; Haase I; Wickenhauser C; Pfister H
    J Invest Dermatol; 2008 Sep; 128(9):2310-5. PubMed ID: 18401427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor prevention in HPV8 transgenic mice by HPV8-E6 DNA vaccination.
    Marcuzzi GP; Awerkiew S; Hufbauer M; Schädlich L; Gissmann L; Eming S; Pfister H
    Med Microbiol Immunol; 2014 Jun; 203(3):155-63. PubMed ID: 24446083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus 5 and 8 E6 downregulate interleukin-8 secretion in primary human keratinocytes.
    Akgül B; Bostanci N; Westphal K; Nindl I; Navsaria H; Storey A; Pfister H
    J Gen Virol; 2010 Apr; 91(Pt 4):888-92. PubMed ID: 20007354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological responses in human papillomavirus 16 E6/E7-transgenic mice to E7 protein correlate with the presence of skin disease.
    Frazer IH; Leippe DM; Dunn LA; Liem A; Tindle RW; Fernando GJ; Phelps WC; Lambert PF
    Cancer Res; 1995 Jun; 55(12):2635-9. PubMed ID: 7540107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific betapapillomaviruses associated with squamous cell carcinoma of the skin inhibit UVB-induced apoptosis of primary human keratinocytes.
    Struijk L; van der Meijden E; Kazem S; Ter Schegget J; de Gruijl FR; Steenbergen RDM; Feltkamp MCW
    J Gen Virol; 2008 Sep; 89(Pt 9):2303-2314. PubMed ID: 18753241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E7 oncoprotein of human papillomavirus type 16 expressed constitutively in the epidermis has no effect on E7-specific B- or Th-repertoires or on the immune response induced or sustained after immunization with E7 protein.
    Herd K; Fernando GJ; Dunn LA; Frazer IH; Lambert P; Tindle RW
    Virology; 1997 Apr; 231(1):155-65. PubMed ID: 9143315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted expression of bcl-2 to murine basal epidermal keratinocytes results in paradoxical retardation of ultraviolet- and chemical-induced tumorigenesis.
    Rossiter H; Beissert S; Mayer C; Schön MP; Wienrich BG; Tschachler E; Kupper TS
    Cancer Res; 2001 May; 61(9):3619-26. PubMed ID: 11325830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human papillomavirus type 8 E2 gene encodes a transforming activity sufficient for skin tumor formation in transgenic mice.
    McLaughlin-Drubin M; Münger K
    J Invest Dermatol; 2008 Sep; 128(9):2142-4. PubMed ID: 18695686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Keratinocyte-specific stat3 heterozygosity impairs development of skin tumors in human papillomavirus 8 transgenic mice.
    De Andrea M; Rittà M; Landini MM; Borgogna C; Mondini M; Kern F; Ehrenreiter K; Baccarini M; Marcuzzi GP; Smola S; Pfister H; Landolfo S; Gariglio M
    Cancer Res; 2010 Oct; 70(20):7938-48. PubMed ID: 20876801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted disruption of the epidermal growth factor receptor inhibits development of papillomas and carcinomas from human papillomavirus-immortalized keratinocytes.
    Woodworth CD; Gaiotti D; Michael E; Hansen L; Nees M
    Cancer Res; 2000 Aug; 60(16):4397-402. PubMed ID: 10969784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A transgenic mouse model (TG.AC) for skin carcinogenesis: inducible transgene expression as a second critical event.
    Hansen LA; Spalding JW; French JE; Tennant RW
    Prog Clin Biol Res; 1995; 391():223-35. PubMed ID: 8532720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels.
    Larcher F; Robles AI; Duran H; Murillas R; Quintanilla M; Cano A; Conti CJ; Jorcano JL
    Cancer Res; 1996 Dec; 56(23):5391-6. PubMed ID: 8968091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultraviolet B(UVB)-induced cox-2 expression in murine skin: an immunohistochemical study.
    Athar M; An KP; Morel KD; Kim AL; Aszterbaum M; Longley J; Epstein EH; Bickers DR
    Biochem Biophys Res Commun; 2001 Feb; 280(4):1042-7. PubMed ID: 11162632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgenic animal models of human papillomavirus-dependent disease (Review).
    Eckert RL; Crish JF; Balasubramanian S; Rorke EA
    Int J Oncol; 2000 May; 16(5):853-70. PubMed ID: 10762621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.